Cre8™ Drug Eluting Stent System
Coronary stent
Drug releasing formulation
Device specifications
Abluminal Reservoir Technology
Controlled and directed drug elution as a result of the Abluminal Reservoir Technology
Product Advantages
Amphilimus™ Formulation
Optimal efficacy achieved through an homogeneous drug distribution and improved bioavailability due to the proprietary Amphilimus™ formulation, which is the combination of Sirolimus and an organic acid
Bio Inducer Surface
Proven bio and haemo-compatibility enabled by the Bio Inducer Surface coating, which accelerates the rate of endothelization and reduces thrombogenicity
© Copyright 2015. All Rights Reserved.